Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.

Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and ...

The first thing the ad shows is a scale. Over the soundtrack of Childish Gambino’s anthem “This is America,” a narrator laments the nation’s obesity crisis and “the system” that is “built to keep us ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Gov. Ned Lamont eyed Medicaid reimbursement rates, a hospital tax restructuring and pharmaceutical costs in his biennial ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

Sen. Dick Durbin (D-Ill.) and Sen. Dr. Roger Marshall (R-Kan.) sent a letter to Food and Drug Administration acting ...